IL-1RA inhibits esophageal carcinogenesis and lymphangiogenesis via downregulating VEGF-C and MMP9

Interleukin-1 receptor antagonist (IL-1RA) has been shown to play an important role in cancer progression. However, its pathogenic effects and molecular mechanism in the malignant progression of esophageal squamous cell carcinoma (ESCC) remain largely unknown. This study was designed to explore the...

Descripción completa

Detalles Bibliográficos
Autores principales: Shen, Zhimin, Zhang, Peipei, Zhang, Weiguang, Luo, Fei, Xu, Hui, Chen, Shuchen, Kang, Mingqiang
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer Berlin Heidelberg 2023
Materias:
Original Article
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10191916/
https://www.ncbi.nlm.nih.gov/pubmed/37198330
http://dx.doi.org/10.1007/s10142-023-01049-5

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10191916/
https://www.ncbi.nlm.nih.gov/pubmed/37198330
http://dx.doi.org/10.1007/s10142-023-01049-5

Ejemplares similares